Debunking the Arguments for Vaccine Apartheid
“Wait your turn” is not epidemiologically sound
The Biden administration’s (carefully worded) support for a WTO IP waiver on vaccines may not be the full-throated support the issue warrants, but it was still a complete reversal of decades of subservience to Big Pharma, and the industry is waging all-out war.
The arguments against allowing poor countries to make their own vaccines are a mix of racist condescension (“poor brown people are too primitive to make high-tech vaccines”), misdirection (“patents aren’t the problem”) and bad faith (“we don’t have enough materials”).
Writing for Counterpunch, Sonali Kolhatkar teases apart each of these arguments. Take the argument that poor countries can’t make vaccines — laughable on its face, given India’s centrality to the world’s vaccine supply.
Why Big Pharma's Arguments Against Patent Waivers Don't Add Up - CounterPunch.org
Days after he publicly opposed the waiving of patents for lifesaving COVID-19 vaccines, billionaire philanthropist Bill…
The problem isn’t that India doesn’t know how to make vaccines — the problem is that India’s brutal, variant-driven outbreak has caused the country to hit pause on exports, halting the supply of vaccines to much of sub-Saharan Africa.
Biden Has the Power to Vaccinate the World
He should use it. Author and public health expert Coordinator of the AccessIBSA project As the number of COVID-19 cases…
The idea that poor countries are especially prone to unsafe practices that make people hesitant to get vaccinated is pretty rich, given the U.S. experience, where government cronies raked in millions of dollars while spoiling millions of vaccine doses.
Before ruining millions of vaccines, Emergent failed inspections, raked in cash
When contract-manufacturer Emergent BioSolutions contaminated at least 15 million doses of Johnson & Johnson's COVID-19…
Countries in the Global South can make their own vaccines, but only if the WTO green-lights it. It’s not enough for Moderna to promise not to…